Reviewed,
UniProtKB/Swiss-Prot P18031 (PTN1_HUMAN)
Last modified
November 25, 2008.
Version 119.
History...
Clusters with 100%,
90%,
50% identity |
Documents (6) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Tyrosine-protein phosphatase non-receptor type 1 EC=3.1.3.48 Alternative name(s): Protein-tyrosine phosphatase 1B Short name=PTP-1B | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 435 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May play an important role in CKII- and p60c-src-induced signal transduction cascades By similarity. |
| Catalytic activity | Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate. |
| Subcellular location | Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side. |
| Post-translational modification | Oxidized on Cys-215; the Cys-SOH formed in response to redox signaling reacts with the alpha-amido of the following residue to form a 4-amino-3-isothiazolidinone serine cross-link, triggering a conformational change that inhibits substrate binding and activity. The active site can be restored by reduction. |
| Polymorphism | Genetic variation in PTPN1 may influence abdominal body fat distribution [MIM:609830]. |
| Sequence similarities | Belongs to the protein-tyrosine phosphatase family. Non-receptor class 1 subfamily. Contains 1 tyrosine-protein phosphatase domain. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Endoplasmic reticulum Membrane |
| Coding sequence diversity | Polymorphism |
| Molecular function | Hydrolase Protein phosphatase |
| PTM | Acetylation Oxidation Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | protein amino acid dephosphorylation Inferred from electronic annotation. Source: InterPro |
| Cellular component | endoplasmic reticulum membrane Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein binding Inferred from physical interaction. Source: IntAct protein tyrosine phosphatase activityInferred from direct assay. Source: UniProtKB zinc ion bindingInferred from direct assay. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| ACTN1 | P12814 | 1 | EBI-968788,EBI-351710 | |
| Cdh2 | P15116 | 3 | EBI-968788,EBI-397974 | From a different organism. |
| GHR | P10912 | 2 | EBI-968788,EBI-286316 | |
| INSR | P06213 | 1 | EBI-968788,EBI-475899 | |
| PIAS1 | O75925 | 1 | EBI-968788,EBI-629434 | |
| Sumo1 | P63166 | 1 | EBI-968788,EBI-80152 | From a different organism. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 435 | 435 | Tyrosine-protein phosphatase non-receptor type 1 | PRO_0000094748 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 3 – 277 | 275 | Tyrosine-protein phosphatase | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 215 | 1 | Phosphocysteine intermediate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 20 | 1 | Phosphotyrosine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 50 | 1 | Phosphoserine; by PKB/AKT1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 295 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 352 | 1 | Phosphoserine | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 378 | 1 | Phosphoserine; by PKC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 386 | 1 | Phosphoserine; by CDC2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 393 | 1 | Phosphoserine By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 215 ↔ 216 | 4-amino-3-isothiazolidinone serine (Cys-Ser); in inhibited form | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 381 | 1 | G → S: dbSNP rs16995304. | VAR_022013 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 387 | 1 | P → L Associated with low glucose tolerance. dbSNP rs16995309. | VAR_022014 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 50 | 1 | S → A or D: No phosphorylation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 3 – 13 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 16 – 26 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 33 – 36 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 38 – 43 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 53 – 55 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 56 – 58 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 74 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 75 – 78 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 79 – 84 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 89 – 91 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 92 – 101 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 106 – 109 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 113 – 115 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 133 – 135 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 136 – 139 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 140 – 149 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 162 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 163 – 165 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 168 – 176 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 188 – 200 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 201 – 204 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 211 – 214 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 216 – 219 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 220 – 238 | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 241 – 243 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 246 – 253 | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 254 – 256 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 264 – 281 | 18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 287 – 295 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of a cDNA for a major human protein-tyrosine-phosphatase." Chernoff J., Schievella A.R., Jost C.A., Erikson R.L., Neel B.G. Proc. Natl. Acad. Sci. U.S.A. 87:2735-2739(1990) [PubMed: 2157211] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Placenta. |
| [2] | "Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B." Brown-Shimer S., Johnson K.A., Lawrence J.B., Johnson C., Bruskin A., Green N.R., Hill D.E. Proc. Natl. Acad. Sci. U.S.A. 87:5148-5152(1990) [PubMed: 2164224] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. Tissue: Placenta. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Eye and Lymph. |
| [6] | "Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins." Charbonneau H., Tonks N.K., Kumar S., Diltz C.D., Harrylock M., Cool D.E., Krebs E.G., Fischer E.H., Walsh K.A. Proc. Natl. Acad. Sci. U.S.A. 86:5252-5256(1989) [PubMed: 2546149] [Abstract] Cited for: PROTEIN SEQUENCE OF 1-321. Tissue: Placenta. |
| [7] | "Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation." Flint A.J., Gebbink M.F.G.B., Franza B.R. Jr., Hill D.E., Tonks N.K. EMBO J. 12:1937-1946(1993) [PubMed: 8491187] [Abstract] Cited for: PHOSPHORYLATION AT SER-352; SER-378 AND SER-386. |
| [8] | "The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence." Frangioni J.V., Beahm P.H., Shifrin V., Jost C.A., Neel B.G. Cell 68:545-560(1992) [PubMed: 1739967] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [9] | "Phosphorylation of PTP1B at Ser(50) by Akt impairs its ability to dephosphorylate the insulin receptor." Ravichandran L.V., Chen H., Li Y., Quon M.J. Mol. Endocrinol. 15:1768-1780(2001) [PubMed: 11579209] [Abstract] Cited for: PHOSPHORYLATION AT SER-50, MUTAGENESIS OF SER-50. |
| [10] | "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells." Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J. Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-20, MASS SPECTROMETRY. |
| [11] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-295, MASS SPECTROMETRY. Tissue: Epithelium. |
| [12] | "Crystal structure of human protein tyrosine phosphatase 1B." Barford D., Flint A.J., Tonks N.K. Science 263:1397-1404(1994) [PubMed: 8128219] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 1-321. |
| [13] | "Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design." Puius Y.A., Zhao Y., Sullivan M., Lawrence D.S., Almo S.C., Zhang Z.Y. Proc. Natl. Acad. Sci. U.S.A. 94:13420-13425(1997) [PubMed: 9391040] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-298 OF MUTANT SER-215. |
| [14] | "Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography." Pannifer A.D., Flint A.J., Tonks N.K., Barford D. J. Biol. Chem. 273:10454-10462(1998) [PubMed: 9553104] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 1-285. |
| [15] | "Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics." Groves M.R., Yao Z.-J., Roller P.P., Burke T.R. Jr., Barford D. Biochemistry 37:17773-17783(1998) [PubMed: 9922143] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1-298. |
| [16] | "Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate." Salmeen A., Andersen J.N., Myers M.P., Meng T.-C., Hinks J.A., Tonks N.K., Barford D. Nature 423:769-773(2003) [PubMed: 12802338] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-321, OXIDATION AT CYS-215, CROSS-LINK 215-CYS-SER-216. |
| [17] | "Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B." Van Montfort R.L.M., Congreve M., Tisi D., Carr R., Jhoti H. Nature 423:773-777(2003) [PubMed: 12802339] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1-321, OXIDATION AT CYS-215, CROSS-LINK 215-CYS-SER-216. |
| [18] | "Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism." Ukkola O., Rankinen T., Lakka T., Leon A.S., Skinner J.S., Wilmore J.H., Rao D.C., Kesaeniemi Y.A., Bouchard C. Obes. Res. 13:829-834(2005) [PubMed: 15919835] [Abstract] Cited for: ASSOCIATION OF VARIANT LEU-387 WITH LOW GLUCOSE TOLERANCE, INVOLVEMENT IN ABDOMINAL BODY FAT DISTRIBUTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M31724 mRNA. Translation: AAA60223.1. M33689 mRNA. Translation: AAA60157.1. M33684 M33685 Genomic DNA. Translation: AAA60158.1. BT006752 mRNA. Translation: AAP35398.1. AL133230, AL034429 Genomic DNA. Translation: CAC00618.2. AL034429, AL133230 Genomic DNA. Translation: CAI23215.1. BC015660 mRNA. Translation: AAH15660.1. BC018164 mRNA. Translation: AAH18164.1. | |||||||||||||||||||
| PIR | TPHUN1. A35992. | ||||||||||||||||||
| RefSeq | NP_002818.1. | ||||||||||||||||||
| UniGene | Hs.417549 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||

Clusters with